Home NDC 69189-0752 CRESTOR
Product NDC 69189-0752
11-digit product format 691890752
Labeler code 69189
Product ID 69189-0752_2e93067b-bc8b-4b88-b256-59efab5167b5
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Rosuvastatin calcium
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Avera McKennan Hospital
Application NDA021366
Marketing category NDA
Marketing start 2016-04-13
Marketing end 0000-00-00
Substance ROSUVASTATIN CALCIUM
Active strength 20 mg/1
Pharmacologic classes HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 69189-0752-1 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 69189-0752-1 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 69189-0752-1 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 69189-0752-1 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 69189-0752-1 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 69189-0752-1 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 69189-0752-1 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 69189-0752-1 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 69189-0752-1 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 69189-0752-1 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 69189-0752-1 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 69189-0752-1 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 69189-0752-1 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 69189-0752-1 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 69189-0752-1 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 69189-0752-1 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 69189-0752-1 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 69189-0752-1 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 69189-0752-1 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 69189-0752-1 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 69189-0752-1 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 69189-0752-1 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021366-002 CRESTOR ROSUVASTATIN CALCIUM EQ 5MG BASE TABLET / ORAL AB RLD 2003-08-12 N021366-003 CRESTOR ROSUVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB RLD 2003-08-12 N021366-004 CRESTOR ROSUVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB RLD 2003-08-12 N021366-005 CRESTOR ROSUVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB RLD, RS 2003-08-12
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 168 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N021366-002 CRESTOR EQ 5MG BASE TABLET / ORAL AB RLD 2003-08-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021366-003 CRESTOR EQ 10MG BASE TABLET / ORAL AB RLD 2003-08-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021366-004 CRESTOR EQ 20MG BASE TABLET / ORAL AB RLD 2003-08-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021366-005 CRESTOR EQ 40MG BASE TABLET / ORAL AB RLD, RS 2003-08-12 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021366-002 CRESTOR EQ 5MG BASE TABLET / ORAL AB RLD 2003-08-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021366-003 CRESTOR EQ 10MG BASE TABLET / ORAL AB RLD 2003-08-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021366-004 CRESTOR EQ 20MG BASE TABLET / ORAL AB RLD 2003-08-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021366-005 CRESTOR EQ 40MG BASE TABLET / ORAL AB RLD, RS 2003-08-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021366-002 CRESTOR EQ 5MG BASE TABLET / ORAL AB RLD 2003-08-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021366-003 CRESTOR EQ 10MG BASE TABLET / ORAL AB RLD 2003-08-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021366-004 CRESTOR EQ 20MG BASE TABLET / ORAL AB RLD 2003-08-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021366-005 CRESTOR EQ 40MG BASE TABLET / ORAL AB RLD, RS 2003-08-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021366-002 CRESTOR EQ 5MG BASE TABLET / ORAL AB RLD 2003-08-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021366-003 CRESTOR EQ 10MG BASE TABLET / ORAL AB RLD 2003-08-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021366-004 CRESTOR EQ 20MG BASE TABLET / ORAL AB RLD 2003-08-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021366-005 CRESTOR EQ 40MG BASE TABLET / ORAL AB RLD, RS 2003-08-12 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021366-002 CRESTOR EQ 5MG BASE TABLET / ORAL AB RLD 2003-08-12 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021366-003 CRESTOR EQ 10MG BASE TABLET / ORAL AB RLD 2003-08-12 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021366-004 CRESTOR EQ 20MG BASE TABLET / ORAL AB RLD 2003-08-12 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021366-005 CRESTOR EQ 40MG BASE TABLET / ORAL AB RLD, RS 2003-08-12 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021366-002 CRESTOR EQ 5MG BASE TABLET / ORAL AB RLD 2003-08-12 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021366-003 CRESTOR EQ 10MG BASE TABLET / ORAL AB RLD 2003-08-12 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021366-004 CRESTOR EQ 20MG BASE TABLET / ORAL AB RLD 2003-08-12 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021366-005 CRESTOR EQ 40MG BASE TABLET / ORAL AB RLD, RS 2003-08-12 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021366-002 CRESTOR EQ 5MG BASE TABLET / ORAL AB RLD 2003-08-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021366-003 CRESTOR EQ 10MG BASE TABLET / ORAL AB RLD 2003-08-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021366-004 CRESTOR EQ 20MG BASE TABLET / ORAL AB RLD 2003-08-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021366-005 CRESTOR EQ 40MG BASE TABLET / ORAL AB RLD, RS 2003-08-12 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021366-002 CRESTOR EQ 5MG BASE TABLET / ORAL AB RLD 2003-08-12 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021366-003 CRESTOR EQ 10MG BASE TABLET / ORAL AB RLD 2003-08-12 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021366-004 CRESTOR EQ 20MG BASE TABLET / ORAL AB RLD 2003-08-12 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021366-005 CRESTOR EQ 40MG BASE TABLET / ORAL AB RLD, RS 2003-08-12 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021366-002 CRESTOR EQ 5MG BASE TABLET / ORAL AB RLD 2003-08-12 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021366-003 CRESTOR EQ 10MG BASE TABLET / ORAL AB RLD 2003-08-12 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021366-004 CRESTOR EQ 20MG BASE TABLET / ORAL AB RLD 2003-08-12 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021366-005 CRESTOR EQ 40MG BASE TABLET / ORAL AB RLD, RS 2003-08-12 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021366-002 CRESTOR EQ 5MG BASE TABLET / ORAL AB RLD 2003-08-12 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021366-003 CRESTOR EQ 10MG BASE TABLET / ORAL AB RLD 2003-08-12 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021366-004 CRESTOR EQ 20MG BASE TABLET / ORAL AB RLD 2003-08-12 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021366-005 CRESTOR EQ 40MG BASE TABLET / ORAL AB RLD, RS 2003-08-12 d8e5a09893c0…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 168 observed states.
Observed Orange Book patent history# Patent history page 1 of 6 · 222 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021366-002 6858618*PED 2022-06-17 Pediatric extension 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021366-003 6858618*PED 2022-06-17 Pediatric extension 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021366-004 6858618*PED 2022-06-17 Pediatric extension 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021366-005 6858618*PED 2022-06-17 Pediatric extension 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021366-002 6858618*PED 2022-06-17 Pediatric extension 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021366-003 6858618*PED 2022-06-17 Pediatric extension 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021366-004 6858618*PED 2022-06-17 Pediatric extension 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021366-005 6858618*PED 2022-06-17 Pediatric extension 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021366-002 6858618*PED 2022-06-17 Pediatric extension 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021366-003 6858618*PED 2022-06-17 Pediatric extension 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021366-004 6858618*PED 2022-06-17 Pediatric extension 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021366-005 6858618*PED 2022-06-17 Pediatric extension 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021366-002 6316460 2020-08-04 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-002 6316460*PED 2021-02-04 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-002 6858618 2021-12-17 U-618 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-002 6858618 2021-12-17 U-1807 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-002 6858618 2021-12-17 U-1032 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-002 6858618*PED 2022-06-17 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-003 6316460 2020-08-04 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-003 6316460*PED 2021-02-04 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-003 6858618 2021-12-17 U-1032 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-003 6858618 2021-12-17 U-618 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-003 6858618 2021-12-17 U-1807 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-003 6858618*PED 2022-06-17 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-004 6316460 2020-08-04 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-004 6316460*PED 2021-02-04 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-004 6858618 2021-12-17 U-1032 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-004 6858618 2021-12-17 U-618 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-004 6858618 2021-12-17 U-1807 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-004 6858618*PED 2022-06-17 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-005 6316460 2020-08-04 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-005 6316460*PED 2021-02-04 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-005 6858618 2021-12-17 U-618 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021366-005 6858618*PED 2022-06-17 Pediatric extension 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021366-002 6858618*PED 2022-06-17 Pediatric extension bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021366-003 6858618*PED 2022-06-17 Pediatric extension bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021366-004 6858618*PED 2022-06-17 Pediatric extension bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021366-005 6858618*PED 2022-06-17 Pediatric extension bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021366-002 6316460*PED 2021-02-04 Pediatric extension 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021366-002 6858618 2021-12-17 U-618 782e0a99824c…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 100 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 69189-0752-1 CRESTOR 1 in 1 DOSE PACK TABLET, FILM COATED 1 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 69189-0752 CRESTOR (ROSUVASTATIN CALCIUM) TABLET, FILM COATED [AVERA MCKENNAN HOSPITAL] 1 Legacy NDC, 1 package rows 20170411_598ecc9c-bfd4-4247-a2c3-bd0ce5aa20d0.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Crestor ROSUVASTATIN AstraZeneca Pharmaceuticals LP 325a5d0e-9a72-4015-9fcd-1655fb504cee 2026-04-29 Warnings, Adverse reactions Exact identifier application applno (NDA): 021366 application number: NDA021366
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 69189-0752-1 69189075201 1 in 1 DOSE PACK Historical